The Qteros executive team has the strategic vision, industry experience and technical expertise necessary to accelerate the global commercialization of low-cost cellulosic ethanol.
Chief Executive Officer
Mr. Sawka has 19 years of international experience negotiating complex corporate, government and university agreements, and commercializing a broad portfolio of specialty chemicals and materials across multiple markets and countries. His leadership expertise in managing R&D, business, licensing, and acquisition efforts has been demonstrated in both development-stage and large-scale organizations, including Microbia, Cabot Corporation, and 3M. In his role as SVP Commercial Development and Engineering for Qteros, Mr. Sawka has overall responsibility for developing and executing the Company’s global commercialization strategy including spearheading Qteros’ commercial development and partnering initiatives, as well as leading the Company’s engineering and process design initiatives.
Mr. Sawka started his career at the lab bench at 3M, where he is the inventor on two granted patents and was involved in the development, scale-up, and commercialization of several products for the automotive industry. He then led the business development efforts for a microencapsulation technology platform and the commercialization of advanced materials for security applications. During the course of these assignments, Mr. Sawka led and managed numerous cross-functional teams with global representation, and directed manufacturing scale-up activities in multiple plants in the US and Europe.
As the Director of New Business Development and R&D at Cabot, Mr. Sawka continued to bridge technical and business disciplines, leading the development of several technology platforms and the implementation of the associated strategic business plans. These efforts led to additional patent applications, product introductions, partnerships, and an acquisition. Most recently, Mr. Sawka led business development efforts for Microbia with a focus on creating a platform of specialty biomaterials and biofuels leveraging a unique fermentation platform.
Mr. Sawka holds a B.S. in Chemical Engineering from Stanford University, an M.S. in Chemical Engineering from MIT, and an MBA in International Management from the University of St. Thomas.
Christopher J. Dale, Ph.D.
VP Research and Development
Dr. Dale joined Qteros in December 2010 as Vice President, Research and Development (R&D) bringing more than 30 years of commercially focused R&D and manufacturing experience to this position. Dr. Dale is responsible for leading all R&D initiatives, as well as managing Qteros’ joint development collaborations with Praj and other strategic partners around the globe.
Most recently, Dr. Dale served as Head of Microbial Technology for Basel, Switzerland-based Lonza where he led U.S. R&D efforts with a specific focus on bioprocess design, scale-up and technology transfer. Dr. Dale also served as Vice President of Technology for Cambrex Biopharma (which was ultimately acquired by Lonza), where he directed the Company’s process development team to produce new, high-value service offerings for Cambrex customers. Previously, Dr. Dale held senior positions in manufacturing and process development for leading organizations including Covance Biotechnology Services, SmithKline Beecham Biologicals and the Centre for Biochemical Engineering at the University of Birmingham.
Dr. Dale holds a Ph.D. in Biochemistry from the University of Birmingham and a B.Sc. in Microbiology from the University of Wales. He was awarded the prestigious Cambridge Prize for outstanding research achievement and has published more than 40 publications. Dr. Dale currently serves on the editorial team of the Journal of Applied Biochemistry and Biotechnology and holds an editorial board seat for Bioprocess International.